Agenus Inc (AGEN)
13.07
+0.55
(+4.39%)
USD |
NASDAQ |
May 03, 16:00
13.05
-0.02
(-0.15%)
After-Hours: 20:00
Agenus Price: 13.07 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 12.75 | 13.58 | 12.55 | 13.07 | 646765.0 |
May 02, 2024 | 13.52 | 14.04 | 12.34 | 12.52 | 979018.0 |
May 01, 2024 | 11.80 | 13.67 | 11.76 | 13.26 | 933882.0 |
Apr 30, 2024 | 12.76 | 12.76 | 11.05 | 12.12 | 1.184M |
Apr 29, 2024 | 12.11 | 14.24 | 11.77 | 12.76 | 2.828M |
Apr 26, 2024 | 8.60 | 12.23 | 8.45 | 11.69 | 3.367M |
Apr 25, 2024 | 7.35 | 8.47 | 7.20 | 8.30 | 961370.0 |
Apr 24, 2024 | 6.84 | 7.74 | 6.31 | 7.42 | 1.274M |
Apr 23, 2024 | 5.76 | 7.51 | 5.70 | 6.46 | 1.689M |
Apr 22, 2024 | 5.40 | 5.85 | 4.91 | 5.77 | 900544.0 |
Apr 19, 2024 | 4.96 | 5.87 | 4.900 | 5.31 | 1.464M |
Apr 18, 2024 | 5.36 | 6.14 | 4.775 | 4.97 | 1.671M |
Apr 17, 2024 | 6.34 | 6.52 | 5.38 | 5.40 | 1.527M |
Apr 16, 2024 | 6.46 | 6.98 | 6.155 | 6.30 | 1.323M |
Apr 15, 2024 | 8.58 | 9.22 | 6.43 | 6.50 | 1.459M |
Apr 12, 2024 | 8.43 | 8.86 | 7.02 | 8.15 | 1.400M |
Apr 11, 2024 | 8.718 | 8.924 | 8.43 | 8.87 | 349022.0 |
Apr 10, 2024 | 9.40 | 9.598 | 8.802 | 8.922 | 301580.0 |
Apr 09, 2024 | 9.146 | 9.80 | 8.80 | 9.73 | 805236.0 |
Apr 08, 2024 | 9.216 | 9.35 | 8.20 | 9.31 | 1.321M |
Apr 05, 2024 | 10.20 | 10.37 | 9.30 | 10.07 | 608341.0 |
Apr 04, 2024 | 10.80 | 11.18 | 10.00 | 10.12 | 575998.0 |
Apr 03, 2024 | 10.40 | 11.18 | 10.20 | 10.60 | 535179.0 |
Apr 02, 2024 | 11.60 | 11.60 | 10.20 | 10.24 | 482301.0 |
Apr 01, 2024 | 11.80 | 11.83 | 11.22 | 11.75 | 343196.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.97
Minimum
Apr 18 2024
130.05
Maximum
Aug 30 2021
54.96
Average
52.96
Median
May 06 2019
Price Benchmarks
Protalix BioTherapeutics Inc | 1.14 |
InfuSystems Holdings Inc | 7.52 |
PAVmed Inc | 2.07 |
Allogene Therapeutics Inc | 3.07 |
Pfizer Inc | 27.81 |
Price Related Metrics
PS Ratio | 1.495 |
Earnings Yield | -107.1% |
Market Cap | 273.76M |